Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969343 · ClinicalTrials.gov registry record · NA
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
A NA study of Venous Thromboembolism and Adverse Drug Event, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 21,000
- Enrollment target
- 1
- Study location
NCT02969343: Completed NA study of Venous Thromboembolism and Adverse Drug Event, sponsored by Brigham and Women's Hospital.
NCT02969343 is a NA study of Venous Thromboembolism and Adverse Drug Event that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 21,000 participants, above the 5,849-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (259% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02969343, a NA study of Venous Thromboembolism and Adverse Drug Event, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (PSLL) focuses on developing health information technology (HIT) tools to engage patients, family, and professional care team members in reliable identification, assessment, and reduction of patient safety threats in real-time, before they manifest in actual harm.
Primary Outcome
Hospitalizations with the presence of any of the following: Patient Falls with Injury, Severe Hypoglycemia, Inpatient or post hospitalization venous thromboembolism, catheter associated urinary tract infection (CAUTI), Central Line Associated Blood Stream Infection (CLABSI), Opioid related severe adverse drug event, hospital acquired pressure ulcer, severe hospital acquired delirium, rapid response related to arrhythmia
Conditions Studied
Interventions
- BEHAVIORAL Patient Safety health information technology
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,000 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02969343 record still lists
NCT02969343 is an interventional study that assigns participants to a tested intervention. Its 21,000 participants enrollment target places it among the larger protocols in the corpus, above the 5,849-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (259% higher).
The record links to 10 conditions, with Venous Thromboembolism appearing as the primary indexed condition, and to 1 intervention - of which Patient Safety health information technology is the first listed.
NCT02969343 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02969343 about?
NCT02969343 is a clinical study titled "Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered". The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (PSLL) focuses on developing health information technology (HIT) tools to engage patients, family, and professional care team members in reliable identification, assessment, and reduction of patient safety threats in real-time...
What is the current status of trial NCT02969343?
This trial is currently completed. It is a NA study. The enrollment target is 21,000 participants. The study started on 2015-04. Estimated completion is 2018-12.
What conditions does trial NCT02969343 study?
This clinical trial studies the following conditions: Venous Thromboembolism, Adverse Drug Event, Severe Hypoglycemia, Hospital Acquired Pressure Ulcer, Central Line-Associated Bloodstream Infection (CLABSI).
What interventions are being tested in trial NCT02969343?
The interventions under investigation include: Patient Safety health information technology (BEHAVIORAL).
Who is sponsoring clinical trial NCT02969343?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02969343 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02969343's enrollment target sits among peer trials
21,000 3rd of 47 higher than 45 of 47 other Venous Thromboembolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Thromboembolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
RECRUITING · NA
-
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
CLEANer Aspiration for Pulmonary Embolism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia